Component Type: Tutorial
CE: ACPE 2.75 Application UAN: 0286-0000-22-503-L04-P ; CME 2.75; IACET 2.75; RN 2.75
Preregistration required and is an additional fee. Already registered? Log in to DIA's My Account/My Events
This short course will explore machine learning (ML) within the Regulatory/ Pharmacovigilance (PV) landscape. The instructors will provide a high-level introduction to machine learning, including common tools and project tips. We will then evaluate example applications, such evaluation of Single Case Drug-Event-Pair (DEP) causality using the Modified Naranjo Causality Score for ICSRs (MONARCSi). The course will also focus on important non-technical aspects of using ML in PV, including potential approaches to performance evaluation, monitoring over time, maintaining human oversight, reporting, and legal considerations. Since machine learning requires resources from across the organization, this course is designed for anyone interested in sponsoring or joining a machine learning project within their organization.
Registration Info Rate: $350
Need approval in order to attend? Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
Enhance your experience and register for two or more short courses at the same time and receive $50 in savings. Purchase must happen at same time. Discount will be reflected on the last page of the cart.Upon completion of registration, participants will gain access to the following:
- Live Event Access
- Presentation Slides
Return to
DIA 2022 Who should attend?This course is designed for anyone with broad interest in PV, Statistics, or Quality that is interested in sponsoring/participating in machine learning projects applied to Pharmacovigilance (PV).
Learning ObjectivesAt the conclusion of this short course, participants should be able to:
- Discuss key recent advances making Machine Learning in pharmacovigilance practical
- Identify potential use cases in pharmacovigilance
- Assess the potential benefits, limitations, and risks of Machine Learning applied to pharmacovigilance